Company news
Abbott Laboratories news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
April 17, 2026
Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences
April 16, 2026
Illinois Jury Awards Four Families $70 Million in Verdict Against Baby Formula Manufacturer
April 10, 2026
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health
April 9, 2026
Global Medical Nutrition Market to Reach USD 31.1 Billion by 2035, Driven by Preventive Healthcare Across North America, Europe & Asia-Pacific - Key Players Nestlé, Abbott, Danone & DSM Lead Innovation
March 31, 2026
Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform
March 30, 2026
Global Fertility Test Kits Market Grows as At-Home Diagnostics Rise, Led by Abbott, Clearblue
March 27, 2026
Abbott hosts conference call for first-quarter earnings
March 26, 2026
John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening
March 24, 2026
Abbott completes acquisition of Exact Sciences
March 23, 2026
Abbott acquisition of Exact Sciences set to close on March 23, 2026
March 20, 2026
Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management
March 12, 2026
Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team'
March 11, 2026
Abbott Laboratories next‑generation CardioMEMS™ remote heart failure monitoring reader receives FDA approval to enhance patient experience and help detect disease progression
February 27, 2026
Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 Players - Sysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics
February 24, 2026
Abbott declares 409th consecutive quarterly dividend
February 20, 2026
Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation
February 6, 2026
Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook
January 22, 2026
Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms
January 20, 2026
TorHoerman Law Announces $495 Million Jury Verdict in Case Involving Abbott Laboratories
January 16, 2026
Innovative Health Receives 50th FDA Clearance to Reprocess Medical Devices
January 13, 2026
Abbott's FreeStyle Libre 3 Plus Now Covered Across Canada
January 7, 2026
Abbott hosts conference call for fourth-quarter earnings
January 5, 2026
Abbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions
January 5, 2026
Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation
December 22, 2025
Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart
December 18, 2025
Abbott increases quarterly dividend for 54th consecutive year
December 12, 2025
Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data
December 8, 2025
University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives
December 6, 2025
Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement
December 4, 2025
Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments
November 20, 2025
Abbott HeartMates Community Delivers Holiday Cheer in Hallmark Channel's New Movie "The More the Merrier"
November 4, 2025
Abbott Showcases World’s First Dual Chamber Leadless Pacemaker in National Media Tour Featuring Patient Story with YourUpdateTV
October 30, 2025
t: slim X2™ Insulin Pump Now Available with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States
October 29, 2025
Abbott and BIG CARiNG Group Launch Nationwide Influenza Awareness Program to Strengthen Public Health Response Through Early Intervention
October 21, 2025
Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance
October 15, 2025
Abbott's Dissolving Stent Receives Health Canada Approval for Treating Blocked Arteries Below-the-Knee
September 29, 2025
Abbott Hosts Conference Call for Third-Quarter Earnings
September 24, 2025
Abbott Declares 407th Consecutive Quarterly Dividend
September 19, 2025
FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes
September 2, 2025
Abbott's Navitor™ TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis
August 29, 2025
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment
August 26, 2025
Abbott and Big Ten Conference Rally Students, Alumni, and Fans to Save Lives and Win $1 Million for Their School by Donating Blood This College Football Season
August 18, 2025
Abbott Reports Second-Quarter 2025 Results
July 17, 2025
Abbott's Latest-Generation FreeStyle Libre 3 Plus Glucose Sensor Technology Launches in Canada
July 8, 2025
Abbott Hosts Conference Call for Second-Quarter Earnings
June 26, 2025
New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier
June 20, 2025
Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions
June 16, 2025
Abbott Declares 406th Consecutive Quarterly Dividend
June 13, 2025
Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery
May 27, 2025
Calls
The 5 newest of 32 calls. Every call is listed under its year.
- Abbott Laboratories (NYSE:ABT) Q3 2026 Earnings Call
Oct 21, 2026
Transcript - Abbott Laboratories (NYSE:ABT) Q2 2026 Earnings Call
Jul 16, 2026
Transcript - Abbott Laboratories (NYSE:ABT) Q1 2026 Earnings Call
Apr 16, 2026
Transcript - Abbott Laboratories (NYSE:ABT) Q4 2025 Earnings Call
Jan 22, 2026
Transcript - Abbott Laboratories (NYSE:ABT) Q3 2025 Earnings Call
Oct 15, 2025
Transcript
Decks
The 5 newest of 18 decks. Every deck is listed under its year.
- Merger or Acquisition (November 2025)
Merger or acquisition · 13 slides · Nov 20, 2025
- Technical Presentation (October 2025)
Technical · 16 slides · Oct 26, 2025
- Investor Presentation (October 2024)
Investor deck · 41 slides · October 2024
- Conference Presentation (October 2024)
Conference · 24 slides · October 2024
- Technical Presentation (November 2023)
Technical · 8 slides · November 2023